Role of CD4⁺ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

Abstract

Non-alcoholic fatty liver disease (NAFLD), which is considered a liver phenotype of metabolic diseases, is becoming a major cause of chronic liver disease. Multiple factors influence and interact with each other in a complex manner to form this pathological condition. As evidenced by low-grade chronic inflammation in obesity, which is a basic pathological feature of NAFLD, immune cell infiltration can occur in various organs, and immune cell infiltration into the liver plays an important role in the development of steatohepatitis. In recent years, an increasing number of reports indicate the involvement of innate immunity and adaptive immunity in the pathogenesis of NAFLD. CD4⁺ T-cells, which serve as an essential and complex element of the immune system and major regulators of host health and disease, are differentiated into functional T helper 1 (Th1), Th2, Th9, Th17, Th22, T follicular helper, and regulatory T-cells upon antigen stimulation in a special cytokine environment. In NAFLD patients, various pathological conditions such as obesity, diabetes, dyslipidemia, and adipose tissue inflammation coexist. Hence, T-cells can be affected by each of these pathological conditions. This review covers and discusses the reports on NAFLD and its associated pathologies as well as their effects on CD4⁺ T-cells.

Keywords

NAFLD / non-alcoholic fatty liver disease / NASH / MAFLD / T-cell / lymphocyte / adaptive immunity

References

[1] Younossi ZM,Abdelatif D,Henry L.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology2016;64:73-84

[2] Hamaguchi M,Kojima T.Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.World J Gastroenterol2012;18:1508-16 PMCID:PMC3319947

[3] Marchesini G,Bianchi G.Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.Diabetes2001;50:1844-50

[4] Kim D,Kim HJ.Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.Hepatology2013;57:1357-65 PMCID:PMC3622816

[5] Vernon G,Younossi ZM.Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.Aliment Pharmacol Ther2011;34:274-85

[6] Katsiki N,Mantzoros CS.Non-alcoholic fatty liver disease and dyslipidemia: An update.Metabolism2016;65:1109-23

[7] Farrell A,Howell J.Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a western perspective.Hepatoma Res2020;6:18

[8] Wong RJ,Cheung R.Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.Gastroenterology2015;148:547-55

[9] Boudreau DM,Raebel MA.Health care utilization and costs by metabolic syndrome risk factors.Metab Syndr Relat Disord2009;7:305-14

[10] Cotter TG,Holmen J,Krong J.Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system.J Gastroenterol2020;55:722-30

[11] Tiniakos DG,Brunt EM.Nonalcoholic fatty liver disease: pathology and pathogenesis.Annu Rev Pathol2010;5:145-71

[12] Tilg H.Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.Hepatology2010;52:1836-46

[13] Takamura T,Ota T.Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.Endocr J2012;59:745-63

[14] Racanelli V.The liver as an immunological organ.Hepatology2006;43:S54-62

[15] Crispe IN.The liver as a lymphoid organ.Annu Rev Immunol2009;27:147-63

[16] Shuai Z,He X.Adaptive immunity in the liver.Cell Mol Immunol2016;13:354-68 PMCID:PMC4856810

[17] Hu H,Kong M.Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives.J Gastroenterol2020;55:142-58 PMCID:PMC6981320

[18] Marra F.Roles for chemokines in liver disease.Gastroenterology2014;147:577-594.e1

[19] Lalor PF,Grant A.Recruitment of lymphocytes to the human liver.Immunol Cell Biol2002;80:52-64

[20] Van Herck MA,Kwanten WJ.The differential roles of T cells in non-alcoholic fatty liver disease and obesity.Front Immunol2019;10:82 PMCID:PMC6372559

[21] Sutti S.Adaptive immunity: an emerging player in the progression of NAFLD.Nat Rev Gastroenterol Hepatol2020;17:81-92 PMCID:PMC7222953

[22] Sutti S,Locatelli I.Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.Hepatology2014;59:886-97

[23] Her Z,Lim YS.CD4⁺ T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice.Front Immunol2020;11:580968 PMCID:PMC7516019

[24] Chalasani N,Lavine JE.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.Hepatology2018;67:328-57

[25] Matteoni C,Gramlich T,Liu Y.Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity.Gastroenterology1999;116:1413-9

[26] Brunt EM,Di Bisceglie AM,Bacon BR.Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.Am J Gastroenterol1999;94:2467-74

[27] Kleiner DE,Van Natta M.Nonalcoholic Steatohepatitis Clinical Research NetworkDesign and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology2005;41:1313-21

[28] Seike T,Yamada K.Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients.J Gastroenterol2020;55:701-11

[29] Gadd VL,Powell EE.The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.Hepatology2014;59:1393-405

[30] Sheth K.The liver as an immune organ.Curr Opin Crit Care2001;7:99-104

[31] Wick MJ,Reimann J.The hepatic immune system.Crit Rev Immunol2002;22:47-103

[32] Norris S,Doherty DG.Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes.J Hepatol1998;28:84-90

[33] Crispe IN.Hepatic T cells and liver tolerance.Nat Rev Immunol2003;3:51-62

[34] Crispe IN,Klugewitz K,Metz DP.The liver as a site of T-cell apoptosis: graveyard, or killing field?.Immunol Rev2000;174:47-62

[35] Oo YH,Adams DH.The role of chemokines in the recruitment of lymphocytes to the liver.Dig Dis2010;28:31-44 PMCID:PMC2883834

[36] Pan X,Liu A,Chen J.Chemokines in non-alcoholic fatty liver disease: a systematic review and network meta-analysis.Front Immunol2020;11:1802 PMCID:PMC7530185

[37] Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin.N Engl J Med2000;343:1020-34

[38] Banchereau J.Dendritic cells and the control of immunity.Nature1998;392:245-52

[39] Xu XD,Zhou S.Trafficking of recirculating lymphocytes in the rat liver: rapid transmigration into the portal area and then to the hepatic lymph.Liver Int2008;28:319-30

[40] Su L,Chi Y.Mesenteric lymph node CD4⁺ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease.Cell Immunol2019;337:33-41

[41] Hu Y,Li J.Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.J Gastroenterol Hepatol2016;31:676-84

[42] Wu Z,Tan J.Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice.J Cell Mol Med2019;23:3375-85 PMCID:PMC6484337

[43] Tay SS,Roediger B.Intrahepatic activation of naive CD4+ T cells by liver-resident phagocytic cells.J Immunol2014;193:2087-95

[44] Shetty S,Adams DH.Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis.Toxicology2008;254:136-46 PMCID:PMC2637620

[45] Bogdanos DP,Gershwin ME.Liver immunology.Compr Physiol2013;3:567-98 PMCID:PMC4201126

[46] Webb GJ,Krawitt EL.Cellular and molecular mechanisms of autoimmune hepatitis.Annu Rev Pathol2018;13:247-92

[47] Van de Water J,Prindiville T.Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis.J Exp Med1995;181:723-33 PMCID:PMC2191887

[48] Guidotti LG.Immunobiology and pathogenesis of viral hepatitis.Annu Rev Pathol2006;1:23-61

[49] Raza S,Anjum B.Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma.Hepatoma Res2019;5:42 PMCID:PMC6924993

[50] Komura T,Seike T.The efficacy of corticosteroid therapy in a patient with non-alcoholic steatohepatitis overlapping autoimmune hepatitis.Intern Med2018;57:807-12 PMCID:PMC5891518

[51] Seike T,Shimizu Y.A young man with non-alcoholic steatohepatitis and serum anti-mitochondrial antibody positivity.Intern Med2018;57:3093-7 PMCID:PMC6262692

[52] Cotler SJ,Keshavarzian A,Jakate S.Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis.J Clin Gastroenterol2004;38:801-4

[53] Neuschwander-Tetri BA,Bass NM.NASH Clinical Research NetworkClinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.Hepatology2010;52:913-24 PMCID:PMC3070295

[54] Younes R,Petta S.Presence of serum antinuclear antibodies does not impact long-term outcomes in nonalcoholic fatty liver disease.Am J Gastroenterol2020;115:1289-92

[55] Nishimura S,Nagasaki M.CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.Nat Med2009;15:914-20

[56] Cai D,Frantz DF.Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.Nat Med2005;11:183-90 PMCID:PMC1440292

[57] Hotamisligil GS.Inflammation, metaflammation and immunometabolic disorders.Nature2017;542:177-85

[58] Hotamisligil GS.Inflammation and metabolic disorders.Nature2006;444:860-7

[59] Xu H,Yang Q.Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.J Clin Invest2003;112:1821-30 PMCID:PMC296998

[60] Zhao Y,Li J.CD4⁺ T cells in obesity and obesity-associated diseases.Cell Immunol2018;332:1-6

[61] Zhou H.Regulation, communication, and functional roles of adipose tissue-resident CD4⁺ T cells in the control of metabolic homeostasis.Front Immunol2018;9:1961 PMCID:PMC6134258

[62] Tilg H,Adolph TE.The intestinal microbiota fuelling metabolic inflammation.Nat Rev Immunol2020;20:40-54

[63] Tao L,Gong Y.Role and mechanism of the Th17/Treg cell balance in the development and progression of insulin resistance.Mol Cell Biochem2019;459:183-8 PMCID:PMC6679830

[64] Gisterå A.The immunology of atherosclerosis.Nat Rev Nephrol2017;13:368-80

[65] Mailer RKW,Polyzos KA,Hansson GK.Hypercholesterolemia enhances T cell receptor signaling and increases the regulatory T cell population.Sci Rep2017;7:15655 PMCID:PMC5688061

[66] Hooper LV,Macpherson AJ.Interactions between the microbiota and the immune system.Science2012;336:1268-73 PMCID:PMC4420145

[67] Aron-Wisnewsky J,Witjes J.Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.Nat Rev Gastroenterol Hepatol2020;17:279-97

[68] Aron-Wisnewsky J,Nieuwdorp M.Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?.Gastroenterology2020;158:1881-98

[69] Imajo K,Yoneda M.Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.Cell Metab2012;16:44-54

[70] Janeway CA Jr.Innate immune recognition.Annu Rev Immunol2002;20:197-216

[71] González-Navajas JM,Law J.TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice.J Clin Invest2010;120:570-81 PMCID:PMC2810084

[72] Reynolds JM,Chung Y.Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation.Proc Natl Acad Sci U S A2012;109:13064-9 PMCID:PMC3420161

[73] Zanin-Zhorov A,Cahalon L.Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling.J Immunol2007;179:41-4

[74] Wang X,Zhu B.Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis.Microb Pathog2020;142:104009

[75] Rolo AP,Palmeira CM.Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.Free Radic Biol Med2012;52:59-69

[76] Binder CJ,Witztum JL.Innate sensing of oxidation-specific epitopes in health and disease.Nat Rev Immunol2016;16:485-97 PMCID:PMC7097710

[77] Hendrikx T.Oxidation-specific epitopes in non-alcoholic fatty liver disease.Front Endocrinol (Lausanne)2020;11:607011 PMCID:PMC7756077

[78] Cury-Boaventura MF,Curi R.Comparative toxicity of oleic acid and linoleic acid on Jurkat cells.Clin Nutr2004;23:721-32

[79] Cury-Boaventura MF,de Lima TM,Curi R.Comparative toxicity of oleic and linoleic acid on human lymphocytes.Life Sci2006;78:1448-56

[80] Gorjão R,de Lima TM.Regulation of human lymphocyte proliferation by fatty acids.Cell Biochem Funct2007;25:305-15

[81] Jong AJ, Kloppenburg M, Toes RE, Ioan-Facsinay A. Fatty acids, lipid mediators, and T-cell function.Front Immunol2014;5:483 PMCID:PMC4195378

[82] Cooper MD.The evolution of adaptive immune systems.Cell2006;124:815-22

[83] Černý J.Adaptive innate immunity or innate adaptive immunity?.Clin Sci (Lond)2019;133:1549-65

[84] Janeway CA Jr.Approaching the asymptote?.Cold Spring Harb Symp Quant Biol1989;54 Pt 1:1-13

[85] Germain RN.T-cell development and the CD4-CD8 lineage decision.Nat Rev Immunol2002;2:309-22

[86] Germain RN.MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.Cell1994;76:287-99

[87] König R,Germain RN.MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.Nature1992;356:796-8

[88] Saravia J,Chi H.Helper T cell differentiation.Cell Mol Immunol2019;16:634-43 PMCID:PMC6804569

[89] Nakayamada S,Kanno Y.Helper T cell diversity and plasticity.Curr Opin Immunol2012;24:297-302 PMCID:PMC3383341

[90] Abbas AK,Sher A.Functional diversity of helper T lymphocytes.Nature1996;383:787-93

[91] Zhu J.Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.Immunol Rev2010;238:247-62 PMCID:PMC2975272

[92] Luckheeram RV,Verma AD.CD4⁺ T cells: differentiation and functions.Clin Dev Immunol2012;2012:925135 PMCID:PMC3312336

[93] Zhu J.CD4 T cells: fates, functions, and faults.Blood2008;112:1557-69 PMCID:PMC2518872

[94] Campbell JD.T cell chemokine receptor expression in human Th1- and Th2-associated diseases.Arch Immunol Ther Exp (Warsz)2000;48:451-6

[95] MacIver NJ,Rathmell JC.Metabolic regulation of T lymphocytes.Annu Rev Immunol2013;31:259-83 PMCID:PMC3606674

[96] Joseph AM,Sonnenberg GF.Metabolic regulation of innate and adaptive lymphocyte effector responses.Immunol Rev2018;286:137-47 PMCID:PMC6195227

[97] Younossi ZM,Sanyal AJ.From NAFLD to MAFLD: implications of a premature change in terminology.Hepatology2021;73:1194-8

[98] Tilg H.From NAFLD to MAFLD: when pathophysiology succeeds.Nat Rev Gastroenterol Hepatol2020;17:387-8

[99] Eslam M,George J.International Consensus PanelMAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease.Gastroenterology2020;158:1999-2014.e1

[100] Eslam M,Sarin SK.A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.J Hepatol2020;73:202-9

[101] Nieman DC,Nehlsen-cannarella SL.Influence of obesity on immune function.J Am Diet Assoc1999;99:294-9

[102] van der Weerd K,Schrijver B.Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype.Diabetes2012;61:401-8 PMCID:PMC3266399

[103] Overwijk WW.Functions of γC cytokines in immune homeostasis: current and potential clinical applications.Clin Immunol2009;132:153-65 PMCID:PMC2761713

[104] Wong MM.Chemokines: attractive mediators of the immune response.Semin Immunol2003;15:5-14

[105] O'Rourke RW,Scholz MH.Alterations in T-cell subset frequency in peripheral blood in obesity.Obes Surg2005;15:1463-8

[106] Fathy SM.Peripheral blood lymphocyte subsets (CD4+, CD8+ T cells), leptin level and weight loss after laparoscopic greater curvature plication in morbidly obese patients.Arch Med Sci2014;10:886-90 PMCID:PMC4223134

[107] Milner JJ.The impact of obesity on the immune response to infection.Proc Nutr Soc2012;71:298-306 PMCID:PMC4791086

[108] Si, Isoda F, Yamakawa T, Ishihara M, Sekihara H. T lymphopenia in genetically obese rats.Clin Immunol Immunopathol1998;86:219-25

[109] Tanaka S,Ishihara Y,Yamakawa T.T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective.Clin Endocrinol (Oxf)2001;54:347-54

[110] Inzaugarat ME,Billordo LA,Gadano AC.Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis.J Clin Immunol2011;31:1120-30

[111] Maricic I,Eguchi A.Differential activation of hepatic invariant nkt cell subsets plays a key role in progression of nonalcoholic steatohepatitis.J Immunol2018;201:3017-35 PMCID:PMC6219905

[112] Diedrich T,Galante A.Characterization of the immune cell landscape of patients with NAFLD.PLoS One2020;15:e0230307 PMCID:PMC7069622

[113] Brunt EM.Nonalcoholic steatohepatitis: definition and pathology.Semin Liver Dis2001;21:3-16

[114] Gerard C.Chemokines and disease.Nat Immunol2001;2:108-15

[115] Bertola A,Anty R.Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients.PLoS One2010;5:e13577 PMCID:PMC2962651

[116] Inzaugarat ME,Baz P.New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.PLoS One2017;12:e0172900 PMCID:PMC5336246

[117] Zhang F,Li X.Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells.J Dig Dis2016;17:464-74

[118] Sun G,Zhang C.OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis.Cell Rep2018;25:3786-3799.e4

[119] Rolla S,Imarisio C.The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.Clin Sci (Lond)2016;130:193-203

[120] Hansel C,Baues M.The inhibitory T cell receptors PD1 and 2B4 are differentially regulated on CD4 and CD8 T cells in a mouse model of non-alcoholic steatohepatitis.Front Pharmacol2019;10:244 PMCID:PMC6436071

[121] Ma C,Eggert T.NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.Nature2016;531:253-7 PMCID:PMC4786464

[122] Ferreyra Solari NE,Baz P.The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis.J Clin Immunol2012;32:611-21

[123] Rau M,Meertens J.Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver.J Immunol2016;196:97-105

[124] Söderberg C,Eckes K.Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis.APMIS2011;119:412-20

[125] Tang Y,Zhao L.Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.Clin Exp Immunol2011;166:281-90 PMCID:PMC3219903

[126] Alegre NS,Billordo LA.Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease.Clin Mol Hepatol2020;26:216-26 PMCID:PMC7160356

[127] Raphael I,Eagar TN.T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.Cytokine2015;74:5-17 PMCID:PMC4416069

[128] Loetscher P,Bordoli L.CCR5 is characteristic of Th1 lymphocytes.Nature1998;391:344-5

[129] Bonecchi R,Bordignon PP.Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.J Exp Med1998;187:129-34 PMCID:PMC2199181

[130] Szabo SJ,Costa GL,Fathman C.A novel transcription factor, T-bet, directs Th1 lineage commitment.Cell2000;100:655-69

[131] Kaplan MH,Hoey T.Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.Nature1996;382:174-7

[132] Afkarian M,Yang J.T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.Nat Immunol2002;3:549-57

[133] Ouyang W,Weindel K.Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism.Immunity1998;9:745-55

[134] Luo XY,Kawai K.IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.Am J Physiol Gastrointest Liver Physiol2013;305:G891-9

[135] Walker LS.CD4 T cell differentiation in type 1 diabetes.Clin Exp Immunol2016;183:16-29 PMCID:PMC4687517

[136] Vyas SP,Goswami R.Rheumatoid arthritis: 'melting pot' of T helper subsets.Int Rev Immunol2019;38:212-31

[137] Grigoriadis N.ParadigMS GroupA basic overview of multiple sclerosis immunopathology.Eur J Neurol2015;22 Suppl 2:3-13

[138] Kobayashi T,Hisamatsu T.IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.Gut2008;57:1682-9

[139] Bovensiepen CS,Sebode M.TNF-producing Th1 cells are selectively expanded in liver infiltrates of patients with autoimmune hepatitis.J Immunol2019;203:3148-56

[140] Harada K,Kamihira T,Nakanuma Y.Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis.Hepatology2005;41:1329-38

[141] Lin F,Su H.Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis.Hepatology2013;58:314-24

[142] Zhao R,Yi S.Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes.PLoS One2014;9:e85770 PMCID:PMC3894984

[143] Zeng C,Zhang B.The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications.J Mol Med (Berl)2012;90:175-86

[144] McLaughlin T,Lamendola C.T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.Arterioscler Thromb Vasc Biol2014;34:2637-43 PMCID:PMC4445971

[145] Winer S,Paltser G.Normalization of obesity-associated insulin resistance through immunotherapy.Nat Med2009;15:921-9 PMCID:PMC3063199

[146] Hong CP,Yang BG.Gut-specific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice.Gastroenterology2017;152:1998-2010

[147] Khan IM,Perrard JL.Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency.Atherosclerosis2014;233:419-28 PMCID:PMC4094239

[148] Rocha VZ,Sukhova G.Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity.Circ Res2008;103:467-76 PMCID:PMC2740384

[149] Stolarczyk E,Perucha E.Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet.Cell Metab2013;17:520-33 PMCID:PMC3685808

[150] Kintscher U,Hess K.T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.Arterioscler Thromb Vasc Biol2008;28:1304-10

[151] Zhang H,Cao JM.Interferon-gamma induced adipose tissue inflammation is linked to endothelial dysfunction in type 2 diabetic mice.Basic Res Cardiol2011;106:1135-45 PMCID:PMC3947811

[152] Wong N,Cempako GR.Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice.Endocrinology2011;152:3690-9

[153] O'Rourke RW,Metcalf MD.Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice.Metabolism2012;61:1152-61 PMCID:PMC3457921

[154] Garidou L,Klopp P.The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease.Cell Metab2015;22:100-12

[155] Luck H,Chung J.Regulation of obesity-related insulin resistance with gut anti-inflammatory agents.Cell Metab2015;21:527-42

[156] Beaurepaire C,McKay DM.Interferon-gamma regulation of intestinal epithelial permeability.J Interferon Cytokine Res2009;29:133-44

[157] Bruzzì S,Giudici G.B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).Free Radic Biol Med2018;124:249-59

[158] Li Z,Diehl AM.Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.Hepatology2005;42:880-5

[159] Kremer M,Milton RJ.Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.Hepatology2006;44:216-27

[160] Baroni GS,Curto P.Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.Hepatology1996;23:1189-99

[161] Rockey DC.Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.J Investig Med1994;42:660-70

[162] Kado A,Enooku K.Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.J Gastroenterol2019;54:730-41

[163] Pacifico L,Anania C.Increased T-helper interferon-gamma-secreting cells in obese children.Eur J Endocrinol2006;154:691-7

[164] Maher JJ,Ryan JC.Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.Hepatology2008;48:670-8 PMCID:PMC3592568

[165] Gieseck RL 3rd,Wynn TA.Type 2 immunity in tissue repair and fibrosis.Nat Rev Immunol2018;18:62-76

[166] Sallusto F,Mackay CR.Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.J Exp Med1998;187:875-83 PMCID:PMC2212187

[167] D'Ambrosio D,Bonecchi R.Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells.J Immunol1998;161:5111-5

[168] Paul WE.How are T(H)2-type immune responses initiated and amplified?.Nat Rev Immunol2010;10:225-35 PMCID:PMC3496776

[169] Zheng W.The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.Cell1997;89:587-96

[170] Zhu J,Guo L.Stat5 activation plays a critical role in Th2 differentiation.Immunity2003;19:739-48

[171] Hwang ES,Schwartzberg PL.T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3.Science2005;307:430-3

[172] Walker JA.T_H2 cell development and function.Nat Rev Immunol2018;18:121-33

[173] Pellicoro A,Iredale JP.Liver fibrosis and repair: immune regulation of wound healing in a solid organ.Nat Rev Immunol2014;14:181-94

[174] Liu Y,Müllenbach R.IL-13 signaling in liver fibrogenesis.Front Immunol2012;3:116 PMCID:PMC3349963

[175] Foerster F,Gerhold-Ay A.The immune contexture of hepatocellular carcinoma predicts clinical outcome.Sci Rep2018;8:5351 PMCID:PMC5876395

[176] Zeyda M,Prager G.Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients.Obesity (Silver Spring)2011;19:743-8

[177] Festa A,Howard G,Tracy RP.Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).Circulation2000;102:42-7

[178] Tsai S,Zhou AC.Insulin receptor-mediated stimulation boosts T cell immunity during inflammation and infection.Cell Metab2018;28:922-934.e4

[179] Viardot A,Mackay F.Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype.Endocrinology2007;148:346-53

[180] Viardot A,Samocha-Bonet D,Campbell LV.Obesity is associated with activated and insulin resistant immune cells.Diabetes Metab Res Rev2012;28:447-54

[181] Viardot A,Samaras K.The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes.J Clin Endocrinol Metab2010;95:2845-50

[182] Villarreal-Calderón JR,Ramos-González MR.Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery.Oxid Med Cell Longev2019;2019:3940739 PMCID:PMC6925764

[183] Schmitz J,Oldham E.IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.Immunity2005;23:479-90

[184] Miller AM,Hueber AJ.Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.Circ Res2010;107:650-8 PMCID:PMC4254700

[185] Molofsky AB,Liang HE.Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages.J Exp Med2013;210:535-49 PMCID:PMC3600903

[186] Grencis RK.Immunity to helminths: resistance, regulation, and susceptibility to gastrointestinal nematodes.Annu Rev Immunol2015;33:201-25

[187] Su CW,Jiao L.Helminth-induced and Th2-dependent alterations of the gut microbiota attenuate obesity caused by high-fat diet.Cell Mol Gastroenterol Hepatol2020;10:763-78 PMCID:PMC7498948

[188] Su CW,Li Y.Helminth infection protects against high fat diet-induced obesity via induction of alternatively activated macrophages.Sci Rep2018;8:4607 PMCID:PMC5854586

[189] Darkhal P,Ma Y.Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.Int J Obes (Lond)2015;39:1292-9 PMCID:PMC4595909

[190] Kwon H,Tang Y,Vemulapalli P.Adipocyte-specific IKKβ signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway.Cell Rep2014;9:1574-83 PMCID:PMC4268106

[191] Stanya KJ,Liu S.Direct control of hepatic glucose production by interleukin-13 in mice.J Clin Invest2013;123:261-71 PMCID:PMC3533296

[192] Lee CG,Zhu Z.Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).J Exp Med2001;194:809-21 PMCID:PMC2195954

[193] Shimamura T,Husain SR,Nakajima A.Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model.J Immunol2008;181:4656-65

[194] Hart KM,Sciurba JC.Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.Sci Transl Med2017;9:eaal3694

[195] Chen T,Cai Z.Th9 cell differentiation and its dual effects in tumor development.Front Immunol2020;11:1026 PMCID:PMC7251969

[196] Veldhoen M,van Snick J.Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.Nat Immunol2008;9:1341-6

[197] Noelle RJ.Cellular sources and immune functions of interleukin-9.Nat Rev Immunol2010;10:683-7 PMCID:PMC3828627

[198] Chang HC,Goswami R.The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.Nat Immunol2010;11:527-34 PMCID:PMC3136246

[199] Goswami R,Yagi R.STAT6-dependent regulation of Th9 development.J Immunol2012;188:968-75 PMCID:PMC3262957

[200] Staudt V,Klein M.Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells.Immunity2010;33:192-202

[201] Deng Y,Chang C,Lau CS.Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials.Hum Immunol2017;78:120-8

[202] Purwar R,Xiao S.Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.Nat Med2012;18:1248-53 PMCID:PMC3518666

[203] Cui M,Lu J.Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection.J Clin Lab Anal2018;32:e22246 PMCID:PMC6817209

[204] Qin SY,Guo XY.A deleterious role for Th9/IL-9 in hepatic fibrogenesis.Sci Rep2016;6:18694 PMCID:PMC4700496

[205] Tan H,Zhao L.A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways.Clin Exp Pharmacol Physiol2017;44:213-21

[206] Guo X,Wang J.CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway.Biomed Pharmacother2018;105:282-9

[207] Zhan T,Jiang S.Interleukin-9 blockage reduces early hepatic granuloma formation and fibrosis during Schistosoma japonicum infection in mice.Immunology2019;158:296-303 PMCID:PMC6856936

[208] Kaplan MH,Olson MR.The development and in vivo function of T helper 9 cells.Nat Rev Immunol2015;15:295-307 PMCID:PMC4445728

[209] Dalmas E,Abdennour M.Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction.Am J Clin Nutr2011;94:450-8

[210] Hang H,Yang Q,Liu Q.Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy.Mol Vis2014;20:1137-45 PMCID:PMC4124102

[211] Vasanthakumar R,Anand G,Babu S.Serum IL-9, IL-17, and TGF-β levels in subjects with diabetic kidney disease (CURES-134).Cytokine2015;72:109-12 PMCID:PMC6367207

[212] Chen H,Zhang X.Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy.Mol Vis2012;18:219-26 PMCID:PMC3272054

[213] Ouyang W,Zheng Y.The biological functions of T helper 17 cell effector cytokines in inflammation.Immunity2008;28:454-67 PMCID:PMC3424508

[214] Hammerich L,Tacke F.Role of IL-17 and Th17 cells in liver diseases.Clin Dev Immunol2011;2011:345803 PMCID:PMC3010664

[215] Acosta-Rodriguez EV,Geginat J.Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.Nat Immunol2007;8:639-46

[216] Mangan PR,O'Quinn DB.Transforming growth factor-beta induces development of the T(H)17 lineage.Nature2006;441:231-4

[217] Bettelli E,Gao W.Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature2006;441:235-8

[218] Ivanov II,Zhou L.The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.Cell2006;126:1121-33

[219] Durant L,Ramos HL.Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.Immunity2010;32:605-15 PMCID:PMC3148263

[220] Ichiyama K,Sekiya T.Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity.Int Immunol2009;21:881-9

[221] Cui G,Wu L.Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation.J Clin Invest2011;121:658-70 PMCID:PMC3026720

[222] Ichiyama K,Inoue N.Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin.Immunity2011;34:741-54

[223] Laurence A,Davidson TS.Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.Immunity2007;26:371-81

[224] Bystrom J,Taher TE.TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases.Cytokine2018;101:4-13

[225] Geremia A,Allan P,Di Sabatino A.Innate and adaptive immunity in inflammatory bowel disease.Autoimmun Rev2014;13:3-10

[226] Tahmasebinia F.The role of Th17 cells in auto-inflammatory neurological disorders.Prog Neuropsychopharmacol Biol Psychiatry2017;79:408-16

[227] Blauvelt A.The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis.Clin Rev Allergy Immunol2018;55:379-90 PMCID:PMC6244934

[228] Zhang JY,Lin F.Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.Hepatology2010;51:81-91

[229] Lemmers A,Gustot T.The interleukin-17 pathway is involved in human alcoholic liver disease.Hepatology2009;49:646-57

[230] Lan RY,Tsuneyama K.Hepatic IL-17 responses in human and murine primary biliary cirrhosis.J Autoimmun2009;32:43-51 PMCID:PMC3225053

[231] Zhang JP,Xu J.Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.J Hepatol2009;50:980-9

[232] Weiss R,Burgert TS.Obesity and the metabolic syndrome in children and adolescents.N Engl J Med2004;350:2362-74

[233] Winer S,Chan Y.Obesity predisposes to Th17 bias.Eur J Immunol2009;39:2629-35

[234] Du C,Kang J.MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis.Nat Immunol2009;10:1252-9

[235] Vega-Cárdenas M,Cortés-García JD.Increased levels of adipose tissue-resident Th17 cells in obesity associated with miR-326.Immunol Lett2019;211:60-7

[236] Arita Y,Ouchi N.Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochem Biophys Res Commun1999;257:79-83

[237] Surendar J,Karunakaran I.Adiponectin limits IFN-γ and IL-17 producing CD4 T cells in obesity by restraining cell intrinsic glycolysis.Front Immunol2019;10:2555 PMCID:PMC6828851

[238] Endo Y,Matsugae N.Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1.Cell Rep2015;12:1042-55

[239] Wakil SJ,Joshi VC.Fatty acid synthesis and its regulation.Annu Rev Biochem1983;52:537-79

[240] Łuczyński W,Moniuszko M,Bossowski A.Elevated levels of Th17 cells in children with central obesity.Scand J Clin Lab Invest2015;75:595-601

[241] Ahmed M.IL-17 in obesity and adipogenesis.Cytokine Growth Factor Rev2010;21:449-53 PMCID:PMC3259710

[242] Sumarac-Dumanovic M,Ljubic A.Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women.Int J Obes (Lond)2009;33:151-6

[243] Jung C,Strodthoff D.Alterations in systemic levels of Th1, Th2, and Th17 cytokines in overweight adolescents and obese mice.Pediatr Diabetes2017;18:714-21

[244] Cortez-Espinosa N,Martínez-Leija E.CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes.Hum Immunol2015;76:622-30

[245] Chen H,Liao N.Th17 cell frequency and IL-17A concentrations in peripheral blood mononuclear cells and vitreous fluid from patients with diabetic retinopathy.J Int Med Res2016;44:1403-13 PMCID:PMC5536736

[246] Guo H,Yang XG.A high frequency of peripheral blood IL-22(+) CD4(+) T cells in patients with new onset type 2 diabetes mellitus.J Clin Lab Anal2016;30:95-102 PMCID:PMC6806726

[247] Jagannathan-Bogdan M,Shin H.Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.J Immunol2011;186:1162-72 PMCID:PMC3089774

[248] Nicholas DA,Agrawal M.Fatty acid metabolites combine with reduced β oxidation to activate Th17 inflammation in human type 2 diabetes.Cell Metab2019;30:447-461.e5

[249] Arababadi MK,Hassanshahi G.Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?.Diabetes Res Clin Pract2010;87:33-7

[250] Roohi A,Abbasi F.Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls.Biomed Res Int2014;2014:718946 PMCID:PMC4065742

[251] O'Rourke RW.Obesity heats up adipose tissue lymphocytes.Gastroenterology2013;145:282-5 PMCID:PMC4181357

[252] Chuang HC,Lin YT.HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance.Nat Commun2014;5:4602 PMCID:PMC4143962

[253] Zepp J,Li X.IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.Trends Immunol2011;32:232-9 PMCID:PMC3329781

[254] Chen L,Wang H.Mechanisms linking inflammation to insulin resistance.Int J Endocrinol2015;2015:508409 PMCID:PMC4468292

[255] Ohshima K,Jing F.Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance.Hypertension2012;59:493-9

[256] Bertola A,Rousseau D.Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients.Diabetes2012;61:2238-47 PMCID:PMC3425417

[257] Fabbrini E,McCartney SA.Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.Gastroenterology2013;145:366-74.e1 PMCID:PMC3756481

[258] Dalmas E,Caer C.T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.Diabetes2014;63:1966-77

[259] Vonghia L,Schrijvers D.CD4+ROR γ t++ and Tregs in a mouse model of diet-induced nonalcoholic steatohepatitis.Mediators Inflamm2015;2015:239623 PMCID:PMC4503578

[260] Pandolfi J,Lerner M.Purinergic signaling modulates human visceral adipose inflammatory responses: implications in metabolically unhealthy obesity.J Leukoc Biol2015;97:941-9

[261] Pandolfi JB,Sananez I.ATP-induced inflammation drives tissue-resident Th17 cells in metabolically unhealthy obesity.J Immunol2016;196:3287-96

[262] Gilleron J,Ivanov S.Rab4b deficiency in T cells promotes adipose Treg/Th17 imbalance, adipose tissue dysfunction, and insulin resistance.Cell Rep2018;25:3329-3341.e5

[263] Chen Y,Tian X.Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells.PLoS One2014;9:e92450 PMCID:PMC3958510

[264] Wang Q.T cells in adipose tissue: critical players in immunometabolism.Front Immunol2018;9:2509 PMCID:PMC6232870

[265] Pestel J,Bonhomme M,Vidal H.IL-17A contributes to propagation of inflammation but does not impair adipogenesis and/or insulin response, in adipose tissue of obese individuals.Cytokine2020;126:154865

[266] Shin JH,Noh M.Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes.Biochem Pharmacol2009;77:1835-44

[267] Zúñiga LA,Joyce-Shaikh B.IL-17 regulates adipogenesis, glucose homeostasis, and obesity.J Immunol2010;185:6947-59 PMCID:PMC3001125

[268] Ahmed M.IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors.Cytokine2013;61:898-905 PMCID:PMC3595389

[269] Han MS,Perry RJ.Regulation of adipose tissue inflammation by interleukin 6.Proc Natl Acad Sci U S A2020;117:2751-60 PMCID:PMC7022151

[270] Subramaniam R,Bhutta HY,Tavakkoli A.Sleeve gastrectomy and Roux-en-Y gastric bypass attenuate pro-inflammatory small intestinal cytokine signatures.Obes Surg2019;29:3824-32

[271] Pérez MM,Dias MS.Interleukin-17/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model.Immunology2019;156:339-55 PMCID:PMC6418416

[272] Martins LMS,Pereira CA.Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model.Immunology2018:624-36 PMCID:PMC6050211

[273] Giles DA,Divanovic S.IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression.Curr Drug Targets2015;16:1315-23 PMCID:PMC4929857

[274] Harley IT,Giles DA.IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice.Hepatology2014;59:1830-9 PMCID:PMC3975735

[275] Giles DA,Stankiewicz TE.Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis.PLoS One2016;11:e0149783 PMCID:PMC4760740

[276] Xu R,Zhang S.Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice.Acta Biochim Biophys Sin (Shanghai)2013;45:726-33

[277] Tan Z,Jiang R.IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.J Immunol2013;191:1835-44

[278] Gomes AL,Burén S.Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma.Cancer Cell2016;30:161-75

[279] Liu Y,Wang F,Wang J.3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance.Int Immunopharmacol2014;23:489-98

[280] Zhang X,Man K.CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.J Hepatol2016;64:160-70

[281] Duhen T,Jarrossay D,Sallusto F.Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.Nat Immunol2009;10:857-63

[282] Trifari S,Tran EH,Spits H.Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.Nat Immunol2009;10:864-71

[283] Ramirez JM,Sorg O.Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells.Eur J Immunol2010;40:2450-9

[284] Mirshafiey A,El Rouby NM.T-helper 22 cells as a new player in chronic inflammatory skin disorders.Int J Dermatol2015;54:880-8

[285] Tian T,Ma D.Th22 and related cytokines in inflammatory and autoimmune diseases.Expert Opin Ther Targets2013;17:113-25

[286] Mo R,Lai R.Persistently elevated circulating Th22 reversely correlates with prognosis in HBV-related acute-on-chronic liver failure.J Gastroenterol Hepatol2017;32:677-86

[287] Jiang BC,Liu XH,Zhu GZ.Notch signaling regulates circulating T helper 22 cells in patients with chronic hepatitis C.Viral Immunol2017;30:522-32

[288] Lai R,Mo R.Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury.J Hepatol2015;63:148-55

[289] Liang M,Yun Z,Jianping C.The imbalance between Foxp3⁺Tregs and Th1/Th17/Th22 cells in patients with newly diagnosed autoimmune hepatitis.J Immunol Res2018;2018:3753081 PMCID:PMC6040251

[290] Qin S,Huang X,Zhou Y.Th22 cells are associated with hepatocellular carcinoma development and progression.Chin J Cancer Res2014;26:135-41 PMCID:PMC4000908

[291] Zhao RX,Sha S.Increased AHR transcripts correlate with pro-inflammatory T-helper lymphocytes polarization in both metabolically healthy obesity and type 2 diabetic patients.Front Immunol2020;11:1644 PMCID:PMC7406643

[292] Zhao RX,Lu YR.Increased peripheral proinflammatory T helper subsets contribute to cardiovascular complications in diabetic patients.Mediators Inflamm2014;2014:596967 PMCID:PMC3997161

[293] Wu Y,Ge C.Interleukin 22 in liver injury, inflammation and cancer.Int J Biol Sci2020;16:2405-13 PMCID:PMC7378634

[294] Wang X,Manzanillo P.Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes.Nature2014;514:237-41

[295] Sabat R.Deciphering the role of interleukin-22 in metabolic alterations.Cell Biosci2015;5:68 PMCID:PMC4678716

[296] Dudakov JA,van den Brink MR.Interleukin-22: immunobiology and pathology.Annu Rev Immunol2015;33:747-85 PMCID:PMC4407497

[297] Yang L,Wang L.Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22.J Hepatol2010;53:339-47

[298] Hwang S,Xiang X.Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets.Hepatology2020;72:412-29 PMCID:PMC7210045

[299] Zhu J,Zhao X,Cheng M.Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1/STAT3/BAX signaling.Food Funct2018;9:6298-306

[300] Vignali DA,Workman CJ.How regulatory T cells work.Nat Rev Immunol2008;8:523-32 PMCID:PMC2665249

[301] Collison LW,Kuo TT.The inhibitory cytokine IL-35 contributes to regulatory T-cell function.Nature2007;450:566-9

[302] Sakaguchi S,Asano M,Toda M.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol1995;155:1151-64

[303] Read S,Powrie F.Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.J Exp Med2000;192:295-302 PMCID:PMC2193261

[304] Liu Y,Li J,Perruche S.A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells.Nat Immunol2008;9:632-40

[305] Fontenot JD,Gavin MA.A function for interleukin 2 in Foxp3-expressing regulatory T cells.Nat Immunol2005;6:1142-51

[306] Hori S,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science2003;299:1057-61

[307] Burchill MA,Vogtenhuber C,Farrar MA.IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.J Immunol2007;178:280-90

[308] Shevyrev D.Treg heterogeneity, function, and homeostasis.Front Immunol2019;10:3100 PMCID:PMC6971100

[309] Ohkura N,Sakaguchi S.Development and maintenance of regulatory T cells.Immunity2013;38:414-23

[310] Yu H,Flavell RA.Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.Immunology2018;153:161-70 PMCID:PMC5765377

[311] Ling EM,Nguyen XD.Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.Lancet2004;363:608-15

[312] Barnes MJ.Regulatory T cells reinforce intestinal homeostasis.Immunity2009;31:401-11

[313] Mizukoshi E.Immune cell therapy for hepatocellular carcinoma.J Hematol Oncol2019;12:52 PMCID:PMC6542133

[314] Manigold T.T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.Lancet Infect Dis2007;7:804-13

[315] Almeida J,Gonzalez-Quintela A.Decreased peripheral blood CD4+/CD25+ regulatory T cells in patients with alcoholic hepatitis.Alcohol Clin Exp Res2013;37:1361-9

[316] Lan RY,Lian ZX.Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.Hepatology2006;43:729-37

[317] Peiseler M,Franke B.FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.J Hepatol2012;57:125-32

[318] Zheng C,Yoo JK.Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing.Cell2017;169:1342-1356.e16

[319] Donninelli G,Pierdominici M.Distinct blood and visceral adipose tissue regulatory T cell and innate lymphocyte profiles characterize obesity and colorectal cancer.Front Immunol2017;8:643 PMCID:PMC5465245

[320] Wagner NM,Czepluch F.Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.Obesity (Silver Spring)2013;21:461-8

[321] Yun JM,Devaraj S.Effects of epigallocatechin gallate on regulatory T cell number and function in obese v. lean volunteers.Br J Nutr2010;103:1771-7

[322] Agabiti-Rosei C,Piantoni S.Decreased circulating T regulatory lymphocytes in obese patients undergoing bariatric surgery.PLoS One2018;13:e0197178 PMCID:PMC5951588

[323] Qiao YC,He L.Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.J Diabetes Res2016;2016:3694957 PMCID:PMC5061980

[324] Burzyn D,Mathis D.Regulatory T cells in nonlymphoid tissues.Nat Immunol2013;14:1007-13 PMCID:PMC4708287

[325] Cipolletta D.Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential.Immunology2014;142:517-25 PMCID:PMC4107662

[326] Cipolletta D,Li A.PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells.Nature2012;486:549-53 PMCID:PMC3387339

[327] Vasanthakumar A,Xin A.The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells.Nat Immunol2015;16:276-85

[328] Feuerer M,Cipolletta D.Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.Nat Med2009;15:930-9 PMCID:PMC3115752

[329] Eller K,Wolf AM.Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.Diabetes2011;60:2954-62 PMCID:PMC3198056

[330] Ilan Y,Tukpah AM.Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.Proc Natl Acad Sci U S A2010;107:9765-70 PMCID:PMC2906892

[331] Kälin S,Ott VB.A Stat6/Pten axis links regulatory T cells with adipose tissue function.Cell Metab2017;26:475-492.e7 PMCID:PMC5627977

[332] Zeng Q,Xiao L,Bettini M.A unique population: adipose-resident regulatory T cells.Front Immunol2018;9:2075 PMCID:PMC6172295

[333] Piconese S,Burocchi A.A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2.Eur J Immunol2010;40:2902-13

[334] Travers RL,Betts JA,Thompson D.The impact of adiposity on adipose tissue-resident lymphocyte activation in humans.Int J Obes (Lond)2015;39:762-9 PMCID:PMC4424387

[335] Deiuliis J,Shah N.Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers.PLoS One2011;6:e16376 PMCID:PMC3027666

[336] Esser N,De Roover A.Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.Diabetologia2013;56:2487-97

[337] Gyllenhammer LE,Alderete TL.Lower omental t-regulatory cell count is associated with higher fasting glucose and lower β-cell function in adults with obesity.Obesity (Silver Spring)2016;24:1274-82 PMCID:PMC4882248

[338] De Rosa V,Calì G.A key role of leptin in the control of regulatory T cell proliferation.Immunity2007;26:241-55

[339] Frederich RC,Anderson S,Lowell BB.Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action.Nat Med1995;1:1311-4

[340] Fabrizi M,Mavilio M.IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity.Diabetes2014;63:2086-96

[341] Pradhan AD,Rifai N,Ridker PM.C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.JAMA2001;286:327-34

[342] Moore KW,Coffman RL.Interleukin-10 and the interleukin-10 receptor.Annu Rev Immunol2001;19:683-765

[343] Cintra DE,Araújo EP.Interleukin-10 is a protective factor against diet-induced insulin resistance in liver.J Hepatol2008;48:628-37

[344] Kim HJ,Park SY.Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.Diabetes2004;53:1060-7

[345] Exel E, Gussekloo J, de Craen AJ, Frölich M, Bootsma-Van Der Wiel A, Westendorp RG; Leiden 85 Plus Study. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study.Diabetes2002;51:1088-92

[346] Han JM,Speck M,Levings MK.Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity.J Immunol2014;192:623-9

[347] Zhang C,Feng K,Xue W.'Repair' Treg cells in tissue injury.Cell Physiol Biochem2017;43:2155-69

[348] Thompson K,Fallowfield J,Millward-Sadler H.Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis.Hepatology1998;28:1597-606

[349] Louis H,Wu W.Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice.Hepatology1998;28:1607-15

[350] Katz SC,Ahmed N.Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.J Immunol2011;187:1150-6 PMCID:PMC3372324

[351] Zahran WE,Kamel PG.Efficacy of tumor necrosis factor and interleukin-10 analysis in the follow-up of nonalcoholic fatty liver disease progression.Indian J Clin Biochem2013;28:141-6 PMCID:PMC3613495

[352] Paredes-Turrubiarte G,Pérez-Tamayo R.Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.Clin Exp Med2016;16:193-202

[353] Lalazar G,Turgeman I.Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: results of a phase IIa blinded placebo-controlled trial.J Clin Immunol2015;35:399-407

[354] Hockenbery DM,Yin X,Korsmeyer SJ.Bcl-2 functions in an antioxidant pathway to prevent apoptosis.Cell1993;75:241-51

[355] Ma X,Mohamood AR,Ravi R.A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury.Hepatology2007;46:1519-29

[356] Roh YS,Park S.Toll-like receptor-7 signaling promotes nonalcoholic steatohepatitis by inhibiting regulatory T cells in mice.Am J Pathol2018;188:2574-88

[357] Drescher HK,Rosenhain S.L-Selectin/CD62L is a key driver of non-alcoholic steatohepatitis in mice and men.Cells2020;9:1106 PMCID:PMC7290433

[358] Reinhardt RL,Locksley RM.Cytokine-secreting follicular T cells shape the antibody repertoire.Nat Immunol2009;10:385-93 PMCID:PMC2714053

[359] Bauquet AT,Paterson AM.The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells.Nat Immunol2009;10:167-75 PMCID:PMC2742982

[360] Linterman MA,Yu D.IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses.J Exp Med2010;207:353-63 PMCID:PMC2822609

[361] Smith KM,Thomas ER.Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo.J Immunol2000;165:3136-44

[362] Crotty S.Follicular helper CD4 T cells (TFH).Annu Rev Immunol2011;29:621-63

[363] Ma CS,Avery DT.Early commitment of naïve human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12.Immunol Cell Biol2009;87:590-600

[364] Schmitt N,Bentebibel SE.The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells.Nat Immunol2014;15:856-65 PMCID:PMC4183221

[365] Crotty S.T follicular helper cell differentiation, function, and roles in disease.Immunity2014;41:529-42 PMCID:PMC4223692

[366] Nurieva RI,Martinez GJ.Bcl6 mediates the development of T follicular helper cells.Science2009;325:1001-5 PMCID:PMC2857334

[367] Johnston RJ,DiToro D.Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation.Science2009;325:1006-10 PMCID:PMC2766560

[368] Bollig N,Kellner K.Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation.Proc Natl Acad Sci U S A2012;109:8664-9 PMCID:PMC3365194

[369] Liu X,Zhong B.Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development.Nature2014;507:513-8 PMCID:PMC4012617

[370] Choi YS,Xing S.LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6.Nat Immunol2015;16:980-90 PMCID:PMC4545301

[371] Johnston RJ,Diamond JA,Crotty S.STAT5 is a potent negative regulator of TFH cell differentiation.J Exp Med2012;209:243-50 PMCID:PMC3281266

[372] Song W.T follicular helper cell heterogeneity: Time, space, and function.Immunol Rev2019;288:85-96 PMCID:PMC6422039

[373] Wang Q,Chen X,Zhang Y.Dysregulation of circulating CD4+CXCR5+ T cells in type 2 diabetes mellitus.APMIS2015;123:146-51

[374] Zhou J,He Y.Non-obese type 2 diabetes patients present intestinal B cell dysregulations associated with hyperactive intestinal Tfh cells.Mol Immunol2018;97:27-32

[375] Zhan J,Ma H.Reduced inflammatory responses of follicular helper T cell promote the development of regulatory B cells after Roux-en-Y gastric bypass.Clin Exp Pharmacol Physiol2017;44:556-65

[376] Winer DA,Shen L.B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies.Nat Med2011;17:610-7 PMCID:PMC3270885

[377] DeFuria J,Jagannathan-Bogdan M.B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile.Proc Natl Acad Sci U S A2013;110:5133-8 PMCID:PMC3612635

[378] Jagannathan M,Liang Y.TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients.J Immunol2009;183:7461-70 PMCID:PMC2851147

[379] Friedman SL,Rinella M.Mechanisms of NAFLD development and therapeutic strategies.Nat Med2018;24:908-22 PMCID:PMC6553468

[380] Jalali M,Mosallanezhad Z,Imanieh MH.The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.Complement Ther Med2020;48:102283

[381] Pickich MB,Phillips CN.Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis.BMC Res Notes2019;12:496 PMCID:PMC6688243

[382] Coia H,Hou Y.Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.Clin Nutr2021;40:110-9 PMCID:PMC7609491

[383] Yue R,Wei S.Immunoregulatory effect of koumine on nonalcoholic fatty liver disease rats.J Immunol Res2019;2019:8325102 PMCID:PMC6402221

[384] Zhou D,Liu XL.Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.J Gastroenterol Hepatol2017;32:1640-8

[385] Cao M,Zhang B.The effect of polyene phosphatidyl choline intervention on nonalcoholic steatohepatitis and related mechanism.Am J Transl Res2016;8:2325-30 PMCID:PMC4891445

[386] He B,Xie W.The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.BMC Immunol2017;18:33 PMCID:PMC5483270

[387] Imarisio C,Sutti S.Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.Clin Sci (Lond)2012;123:323-32

[388] Cai Y,Liu M.Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.Hepatology2018;68:48-61 PMCID:PMC6033664

[389] Alchera E,Imarisio C.Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity.Transl Res2017;182:75-87

[390] Wu L,Feng J.Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway.Br J Pharmacol2020;177:3760-77 PMCID:PMC7393201

[391] Li S,Fujino M.Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice.PLoS One2017;12:e0187810 PMCID:PMC5679630

[392] Ni Y,Zhuge F.Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E.Sci Rep2015;5:17192 PMCID:PMC4658633

[393] Sugiura M,Ikoma Y.The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects.J Epidemiol2006;16:71-8 PMCID:PMC7560529

[394] Kobori M,Takahashi Y.β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.PLoS One2014;9:e98294 PMCID:PMC4032271

[395] Song X.Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma.Hepatoma Res2020;6:27

[396] Tateishi R,Fujiwara N.A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.J Gastroenterol2019;54:367-76 PMCID:PMC6437291

[397] Benhammou JN,Hussain SK.Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma.Hepatoma Res2020;6:35 PMCID:PMC7367098

[398] Ni L,Dong C.The advancement of immunotherapy in hepatocellular carcinoma.Hepatoma Res2020;6:25

[399] Wang R.Metabolic checkpoints in activated T cells.Nat Immunol2012;13:907-15

[400] Geltink RIK,Pearce EL.Unraveling the complex interplay between T cell metabolism and function.Annu Rev Immunol2018;36:461-88 PMCID:PMC6323527

[401] Yamada K,Sunagozaka H.Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.Liver Int2015;35:582-90

[402] Yamada K,Seike T.Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis.J Gastroenterol Hepatol2019;34:1829-35

[403] Lochner M,Sparwasser T.Fatty acid metabolism in the regulation of T cell function.Trends Immunol2015;36:81-91

[404] Kohjima M,Higuchi N.Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.Int J Mol Med2007;20:351-8

[405] Wai JW,Wong VW.Confounding factors of non-invasive tests for nonalcoholic fatty liver disease.J Gastroenterol2020;55:731-41 PMCID:PMC7376510

[406] Vesely MD,Schreiber RD.Natural innate and adaptive immunity to cancer.Annu Rev Immunol2011;29:235-71

[407] Kang TW,Woller N.Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.Nature2011;479:547-51

[408] Schneider C,Yevsa T.Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.Gut2012;61:1733-43 PMCID:PMC4533880

[409] Unitt E,Gelson W.Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.J Hepatol2006;45:246-53

[410] Unitt E,Marshall A.Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.Hepatology2005;41:722-30

[411] Shen X,Li H,Wang F.Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.J Cancer Res Clin Oncol2010;136:1745-54

[412] Fu J,Liu Z.Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.Gastroenterology2007;132:2328-39

[413] Jia Y,Li Y.Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.PLoS One2015;10:e0117458 PMCID:PMC4331507

[414] Chen DS.Oncology meets immunology: the cancer-immunity cycle.Immunity2013;39:1-10

[415] Inada Y,Seike T.Characteristics of immune response to tumor-associated antigens and immune cell profile in patients with hepatocellular carcinoma.Hepatology2019;69:653-65

[416] Brown ZJ,Ma C.Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4⁺ T cell apoptosis promoting HCC development.Cell Death Dis2018;9:620 PMCID:PMC5966464

[417] Sugiura A.Metabolic Barriers to T Cell Function in Tumors.J Immunol18;200:400-7 PMCID:PMC5777533

[418] Nakahara T,Yoneda M.Japan Study Group of Nonalcoholic Fatty Liver DiseaseType 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.J Gastroenterol2014;49:1477-84

[419] Kawamura Y,Ikeda K.Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.Am J Gastroenterol2012;107:253-61

[420] Tokushige K,Kodama K.Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.J Gastroenterol Hepatol2013;28 Suppl 4:88-92

[421] Goronzy JJ.Mechanisms underlying T cell ageing.Nat Rev Immunol2019;19:573-83 PMCID:PMC7584388

[422] Chattopadhyay PK.Cytometry: today's technology and tomorrow's horizons.Methods2012;57:251-8 PMCID:PMC3374038

[423] Atkuri KR,Neubert H.Mass cytometry: a highly multiplexed single-cell technology for advancing drug development.Drug Metab Dispos2015;43:227-33

[424] Papalexi E.Single-cell RNA sequencing to explore immune cell heterogeneity.Nat Rev Immunol2018;18:35-45

[425] Moro-García MA,Sainz RM.Influence of inflammation in the process of T lymphocyte differentiation: proliferative, metabolic, and oxidative changes.Front Immunol2018;9:339 PMCID:PMC5839096